About Assertio (ASRT)
Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Susp... Read more
- USD0.61
- USD0.66
- USD0.60
- USD1.80
- 4.90%
- 125M
- 309.40k
- 62M
- 0.51
- -44.40%
Stock News
4 hours ago
Rivian: Near-Term Deliveries Cut Has No Bearing On R2's Future
SeekingAlpha
4 hours ago
Rates Spark: Market Discount Shifts To Un-Discounting Some Recession Risks
SeekingAlpha
4 hours ago
Uber: Accelerates AV Ambitions As Growth Shows Signs Of Stalling
SeekingAlpha
4 hours ago
The Next Frontier In Portfolio Design: Keeping Equities While Adding Gold
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
